humanitarian Archived signal

Human medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 6, Status: Authorised

Reported by EMA What Is New Oct 20, 2026 · 13:26 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 7, Status: Authorised13:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Afqlir, aflibercept, Date of authorisation: 13/11/2024, Revision: 7, Status: Authorised13:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 17, Status: Authorised12:54 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Bimervax, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 30/03/2023, Revision: 17, Status: Authorised12:54 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 23, Status: Authorised12:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Enhertu, trastuzumab deruxtecan, Date of authorisation: 18/01/2021, Revision: 23, Status: Authorised12:26 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Date of authorisation: 29/09/2023, Revision: 1, Status: Authorised12:20 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Degarelix Accord, degarelix, Date of authorisation: 29/09/2023, Revision: 1, Status: Authorised12:20 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Skyclarys, omaveloxolone, Date of authorisation: 09/02/2024, Revision: 11, Status: Authorised12:15 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Skyclarys, omaveloxolone, Date of authorisation: 09/02/2024, Revision: 11, Status: Authorised12:15 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 17, Status: Autho…12:08 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 17, Status: Autho…12:08 UTC

INCIDENT EVOLUTION

2 recorded states

Oct 20 · 13:49 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 20 · 14:15 UTC

Headline updatedP2 · 99% quality · 2 sources

Explore this day in the archive →